Medical AI development cost in India, broken down.
Real INR ranges from a feasibility proof-of-concept to a clearance-ready SaMD product, plus what a dedicated ML and regulatory team costs per month. Use the calculator for an instant ballpark, then see exactly what drives the number — data, regulatory process, and clinical validation.
Medical AI cost in India by stage (2026)
Typical all-in cost. Where your project lands depends on modality, regulatory pathway, available annotated data, and the depth of clinical validation your claim needs.
Rule of thumb: start with a feasibility PoC. It answers the one question that decides everything else — does the AI actually work on your data — before you commit to the far larger cost of clearance.
Estimate your medical AI cost
Pick what you need for an instant INR ballpark. For a scoped, fixed estimate, book a feasibility assessment.
Indicative range. Your exact figure depends on scope, integrations and design.
Get a scoped estimateSix things that decide your medical AI budget
Two medical AI projects with the same headline can differ many times over in price. Here is where the money goes.
Data & annotation
Sourcing, de-identifying, and expert-annotating clinical data is slow, specialist work — and often the single largest line item. Existing labelled data lowers cost sharply.
Regulatory pathway
An internal decision-support tool is far cheaper than a cleared diagnostic SaMD. IEC 62304, ISO 13485, and ISO 14971 shape the build from day one, not the end.
Model complexity
Multi-modal and imaging models are heavier than a single-lead signal model. Accuracy targets, rare-class performance, and explainability all add work.
Integrations
DICOM/PACS for imaging, HL7/FHIR for records, and on-device or edge deployment each add real engineering — often where clinical products live or die.
Clinical validation
Proving the model performs on real patients, to the standard a regulator expects, is a project in itself — retrospective at minimum, prospective for higher-risk claims.
Post-market & MLOps
Monitoring, drift detection, re-validation, and — for cleared devices — mandatory post-market surveillance are ongoing costs, not one-offs.
How you pay for a medical AI build
We usually recommend a fixed-scope PoC first, so you prove the AI works and approve one number before the far larger productization spend.
The costs that get bolted on after the quote
The model build is only part of it. These are the line items thin quotes leave out on a regulated medical product.
Data annotation
Expert clinical labelling — often by radiologists, cardiologists, or pathologists — is time-consuming and specialist. Underestimating it is the most common medical-AI budget miss.
Regulatory documentation
The IEC 62304 lifecycle, ISO 14971 risk file, and technical documentation are real engineering effort, not a template. Build them as you go, or pay to reconstruct them before an audit.
Clinical validation
A retrospective study is the minimum; a prospective study for a higher-risk claim is a significant separate cost, plus the regulator or notified-body fees themselves.
Post-market surveillance
For a cleared device, monitoring real-world performance and re-validating as data drifts is a continuing legal obligation — budget for it from launch.
From idea to clearance-ready product, in phases you control
Feasibility & scope
Data review, target claim, regulatory market, and a PoC scoped and priced in INR.
PoC & validation
Train and evaluate one model on your data to prove it works before you commit.
Build to standard
Productize under an IEC 62304 lifecycle with ISO 14971 risk management, in sprints.
Integrate & validate
DICOM/HL7 integration, clinical validation, and the technical evidence file.
Clear & maintain
Support your FDA/CE/CDSCO submission, then monitor and re-validate post-market.
Medical AI cost in India, answered
The pricing, regulatory, and validation questions medical-device and diagnostics teams actually ask before they brief a partner.
How much does medical AI development cost in India?
A feasibility proof-of-concept, one model on your data, typically costs ₹20 lakh to ₹45 lakh. A production model deployed as an internal or decision-support tool runs ₹45 lakh to ₹1.2 crore. A clearance-ready Software-as-a-Medical-Device product, built to IEC 62304 with clinical validation and a regulatory evidence file, runs ₹1.2 crore to ₹3.5 crore or more. Where you land depends on modality, regulatory pathway, and how much clinical validation your claim needs.
Why is medical AI more expensive than regular software?
Three things regular software does not carry. First, clinical data: sourcing, de-identifying, and expert-annotating medical data is slow and specialist work. Second, the regulatory process: building to IEC 62304, ISO 13485, and ISO 14971 means controlled documentation, risk files, and traceability from the first sprint, not paperwork bolted on at the end. Third, clinical validation: proving the model performs on real patients, to the standard a regulator expects. Those three are most of the gap.
What does a medical AI proof-of-concept cost?
A focused PoC, one model, one modality, trained and evaluated on a defined dataset to show whether the idea is technically feasible, typically costs ₹20 lakh to ₹45 lakh and takes 6 to 12 weeks. It is the right first step: it de-risks the hard question (does the AI actually work on your data?) before you commit to the far larger cost of productization and clearance.
Does the cost include FDA or CE clearance?
A build partner does not grant clearance; it builds the software to the standards and produces the technical documentation, risk file, and validation evidence you submit for your own FDA, CE, or CDSCO clearance. A clearance-ready SaMD build includes that evidence trail. The regulator’s own review fees, notified-body costs, and any prospective clinical study are separate and depend on your market and device class.
What drives the cost of a medical AI build?
The biggest drivers are the modality and model complexity (imaging and multi-modal are heavier than a single-lead signal model), the regulatory pathway (an internal decision-support tool is far cheaper than a cleared diagnostic SaMD), the amount and quality of annotated data available, integrations (DICOM/PACS, HL7/FHIR, edge/device deployment), and the depth of clinical validation your claim requires.
What are the ongoing costs after launch?
Budget for cloud and inference infrastructure, model monitoring and drift detection, and periodic re-validation as data and guidelines change. For a cleared device, post-market surveillance is a regulatory obligation, not optional. A dedicated ML and regulatory squad to maintain and extend the product is usually billed monthly, roughly ₹5 lakh to ₹15 lakh depending on team size.
Keep researching
The service, the shortlist, and the related guides.
Have a diagnostic idea that needs AI?
Tell us your data, your target claim, and your regulatory market. We'll come back with a scoped, honest INR estimate and tell you what's buildable — usually within a couple of days.